-
Recombinant Human Oncostatin M: Assay Guide
2026-08-26
Learn how Recombinant Human Oncostatin M (E.coli, Tag Free, Lyophilized), SKU P1045, can address variability in viability, proliferation, and cytokine-release assays. This scenario-based guide covers assay interpretation, reconstitution, controls, cross-model comparisons, and practical vendor-selection criteria.
-
Tetrahydromagnolol for CB2 Signaling Workflows
2026-08-25
Tetrahydromagnolol combines potent peripheral CB2 agonism with GPR55 antagonism, enabling pathway-resolved cannabinoid receptor research rather than single-endpoint screening. This guide translates those properties into receptor, inflammatory, migration, and GPCR-to-cytoskeleton workflows while clearly separating established evidence from testable applications.
-
TUDCA in ER Stress and Metabolic Research
2026-08-25
Tauroursodeoxycholic Acid, or TUDCA, is a taurine-conjugated bile acid derivative used to study ER stress, apoptosis, mitochondrial injury, and metabolic dysfunction. Its strongest value is as a hypothesis-testing chemical chaperone, not as a pathway-specific substitute for genetic or pharmacological validation.
-
Targeted EPO mRNA Nanoparticles for Spinal Cord Repair
2026-08-24
A 2026 Materials Today Bio study developed mannose-modified lipid nanoparticles to deliver erythropoietin mRNA to CD206-enriched inflammatory macrophages and microglia after spinal cord injury. In mice, localized EPO production reduced neuroinflammation and ferroptosis-associated damage while improving axonal preservation and motor recovery, providing a mechanistically informed framework for targeted mRNA nanotherapy.
-
CDK9 inhibitor A3294: Protocol and QC Guide
2026-08-24
CDK9 inhibitor A3294 provides selective CDK9 modulation for transcription elongation and defined HIV-1 propagation studies, with a reported IC50 of 39 nM and limited activity against the listed CDK family members. It is intended for focused pathway experiments rather than pan-CDK profiling, general cell cycle regulation, or long-term storage of working solutions.
-
InstaBlue Protein Stain Solution for Proteomics
2026-08-23
InstaBlue Protein Stain Solution streamlines protein electrophoresis analysis with fixation-free visualization in approximately 5 minutes and reported sensitivity down to 5 ng. Its methanol- and acetic acid-free formulation is especially useful when gel bands must move efficiently from biomedical research protein visualization to quantification or mass spectrometry.
-
CUX2 Neuron Loss and DNA Damage in Neuroinflammation
2026-08-22
The reference study identifies accumulated DNA damage and insufficient double-strand-break repair as a mechanistic basis for the selective loss of CUX2-positive layer 2/3 excitatory neurons in multiple sclerosis and mouse neuroinflammation models. Its human-to-animal-to-cellular design links interferon-γ-driven oxidative stress with neuronal vulnerability and provides a framework for studying cell-type-specific degeneration.
-
NHS-Biotin: Reliable Protein Labeling in Cell Assays
2026-08-21
NHS-Biotin (SKU A8002) provides a practical route to stable amine-reactive labeling for antibody, protein, surface, and intracellular workflows that support cell-based assay interpretation. This scenario-driven guide explains chemistry, compatibility, handling, data normalization, and vendor-selection considerations for reproducible protein detection and purification.
-
Annexin V-APC/7-AAD Apoptosis Kit Workflow
2026-08-20
Build a rapid dual-parameter workflow that separates viable, early apoptotic, late apoptotic, and membrane-compromised cells. The Annexin V-APC/7-AAD Apoptosis Kit is especially useful for linking immune-checkpoint perturbation with tumor-cell and T-cell fate in cancer models.
-
Rab26 Deficiency Disrupts SERT Trafficking in Mice
2026-08-20
The reference study links Rab26 loss to depression- and anxiety-like behaviors, cognitive impairment, altered synaptic physiology, and defective serotonin transporter (SERT) trafficking. Its central innovation is the identification of a Rab26–SERT regulatory pathway connecting membrane transport, autophagic degradation, serotonin uptake, and behavioral phenotypes.
-
Sulfo-NHS-SS-Biotin for Surface Protein Trafficking
2026-08-19
Sulfo-NHS-SS-Biotin combines cell-impermeant surface labeling with a cleavable disulfide linker, making it useful for tracking membrane delivery and recovering labeled proteins. This practical guide connects reversible biotinylation to invadopodium studies of MT1-MMP, EGFR, Munc18c, and syntaxin4 while emphasizing workflow control and troubleshooting.
-
TH287 Sensitizes CRPC Cells to Radiation
2026-08-19
A 2026 study found that TH287 enhanced ionizing-radiation responses in PC-3 and DU-145 castration-resistant prostate cancer cells, with the strongest effect when radiation followed inhibitor exposure by 12 hours. The work adds a practical timing variable to MTH1-based radiosensitization and links the combination to increased apoptosis and cell-cycle disruption.
-
LY2228820: p38 MAP kinase inhibitor workflows
2026-08-18
LY2228820 enables controlled inhibition of p38α/β signaling across biochemical, inflammatory, and cancer research workflows. Its nanomolar biochemical potency, formulation flexibility, and compatibility with phospho-MK2, cytokine, and apoptosis readouts support mechanism-focused experiments rather than single-endpoint screening.
-
Gut-Brain Cholinergic Signaling in Seizure Control
2026-08-18
Jia et al. identify a gut-vagus-brain cholinergic circuit through which Bacteroides fragilis suppresses seizures in mouse models and improves outcomes in a pediatric refractory epilepsy trial. The study connects microbial composition, colonic ChAT-positive cells, vagal transmission, and acetylcholine receptor activation, providing a mechanistic framework for microbiota-based antiseizure research.
-
Anlotinib Hydrochloride in Angiogenesis Assays
2026-08-17
Anlotinib hydrochloride enables a multi-pathway approach to angiogenesis research by targeting VEGFR2, PDGFRβ, FGFR1, and downstream ERK signaling. This practical guide connects endothelial migration, tube formation, mechanistic readouts, and vascular sprouting models with troubleshooting strategies for reproducible cancer research.